Table 1.
Sociodemographic and clinical characteristics of the sample.
| Schizophrenia patients (N = 20) | Healthy controls (N = 20) | Statistics | |||
|---|---|---|---|---|---|
| M | SD | M | SD | ||
| Age | 32.25 | 9.45 | 30.15 | 5.21 | t(29.6) = 0.870, p = 0.390, d = 0.275, 95%CI[-2.78 – 6.98] |
| Education (years) | 11.05 | 2.48 | 11.21 | 1.08 | U = 152.50, p = 0.296, r = 0.245 |
| Gender | χ2 = 0.229, p = 0.633 | ||||
| Male n/% | 17 | 85 | 18 | 90 | |
| PANSS | |||||
| Positive symptoms | 8.65 | 1.93 | |||
| Negative symptoms | 14.80 | 6.96 | |||
| General psychopathology | 26.90 | 5.86 | |||
| Medication (chlorpromazine equivalents) | 771.75 | 468.75 | |||
| Illness duration (years) | 6.41 | 6.19 | |||